fda approved glp-1 agonists New Pill Foundayo (Orforglipron) Gets Approval for Obesity Market Overview: GLP-1 Agonists and

Consistent with these findings, peripherally administered CCK induces cFos immunoreactivity in GLP-1-producing neurons of the hindbrain vagal complex of the NTS [354], and surgical vagal deafferentation reduces CCK-induced NTS neuronal cFos activation by approximately 50% [355]

GLP-1 injections offer several benefits for long-term weight loss, especially for individuals who struggle with managing their weight or have been unsuccessful with other weight loss methods

Off-label use means a medication is prescribed for a purpose other than what it is FDA-approved for, which is common in healthcare

Bisgaard LS, Bosteen MH, Fink LN, Srensen CM, Rosendahl A, Mogensen CK, Rasmussen SE, Rolin B, Nielsen LB, Pedersen TX